These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8842274)

  • 21. Outbreak of foodborne botulism in Alexandria, Egypt: modulating indications for administration of heptavalent botulinum antitoxin.
    Ghitani SA; Ghanem MA; Sultan EA; Atef M; Henaidy MF
    Environ Sci Pollut Res Int; 2022 Mar; 29(12):18305-18308. PubMed ID: 35088256
    [No Abstract]   [Full Text] [Related]  

  • 22. TYPE E BOTULISM. REPORT OF AN OUTBREAK IN MICHIGAN.
    EADIE GA; MOLNER JG; SOLOMON RJ; AACH RD
    JAMA; 1964 Feb; 187():496-9. PubMed ID: 14084821
    [No Abstract]   [Full Text] [Related]  

  • 23. Standardization of the Japanese National Standard, Equine Botulinum Antitoxin Type A, and Factors Affecting Standardization.
    Yutani M; Senoh M; Yano H; Kenri T; Iwaki M
    Jpn J Infect Dis; 2024 Jan; 77(1):16-20. PubMed ID: 37648491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type E botulism.
    Horowitz BZ
    Clin Toxicol (Phila); 2010 Nov; 48(9):880-95. PubMed ID: 21171846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatal outbreak of botulism in Greenland.
    Hammer TH; Jespersen S; Kanstrup J; Ballegaard VC; Kjerulf A; Gelvan A
    Infect Dis (Lond); 2015 Mar; 47(3):190-4. PubMed ID: 25622940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin.
    Yu PA; Lin NH; Mahon BE; Sobel J; Yu Y; Mody RK; Gu W; Clements J; Kim HJ; Rao AK
    Clin Infect Dis; 2017 Dec; 66(suppl_1):S57-S64. PubMed ID: 29293928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Clinical Outcomes of an Equine-derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United States.
    Richardson JS; Parrera GS; Astacio H; Sahota H; Anderson DM; Hall C; Babinchak T
    Clin Infect Dis; 2020 Apr; 70(9):1950-1957. PubMed ID: 31209461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foodborne Botulism, Canada, 2006-2021
    Harris RA; Tchao C; Prystajecky N; Weedmark K; Tcholakov Y; Lefebvre M; Austin JW
    Emerg Infect Dis; 2023 Sep; 29(9):1730-7. PubMed ID: 37610295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulism beaten.
    Buckland J
    Nat Rev Immunol; 2002 Sep; 2(9):628. PubMed ID: 12240638
    [No Abstract]   [Full Text] [Related]  

  • 30. HUMAN BOTULISM DUE TO COMMERCIAL PRODUCTS.
    REED RW; BUTAS CA; GALL RJ
    Can Med Assoc J; 1965 Aug; 93(6):244-7. PubMed ID: 14328038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New targets in the search for preventive and therapeutic agents for botulism.
    Anniballi F; Lonati D; Fiore A; Auricchio B; De Medici D; Locatelli CA
    Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1075-86. PubMed ID: 25089560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter to the editor on Ghitani SA et al. Outbreak of foodborne botulism in Alexandria, Egypt. Modulating indications for administration of heptavalent botulinum antitoxin DOI: 10.1007/s11356-021-14909-z.
    Claytor L
    Environ Sci Pollut Res Int; 2022 Mar; 29(12):18302-18304. PubMed ID: 35031984
    [No Abstract]   [Full Text] [Related]  

  • 33. A Novel Rabbit Spirometry Model of Type E Botulism and Its Use for the Evaluation of Postsymptom Antitoxin Efficacy.
    Diamant E; Pass A; Rosen O; Ben David A; Torgeman A; Barnea A; Tal A; Rosner A; Zichel R
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity.
    Khouri JM; Motter RN; Arnon SS
    Vaccine; 2018 Apr; 36(15):2041-2048. PubMed ID: 29475762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outbreak of Foodborne Botulism Associated with a Commercially Produced Multipack Potato Product, Colorado: September 2019.
    Gayou N; Plumb ID; Edwards L; Pomeroy M; Herlihy RK; Johnson R; Pattison K; Dykes J; Gómez GA; Jervis RH
    Foodborne Pathog Dis; 2022 Oct; 19(10):713-715. PubMed ID: 36149750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulism in the United States: a clinical and epidemiologic review.
    Shapiro RL; Hatheway C; Swerdlow DL
    Ann Intern Med; 1998 Aug; 129(3):221-8. PubMed ID: 9696731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exposure-Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product.
    Beliveau M; Anderson D; Barker D; Kodihalli S; Simard E; Hall C; Richardson JS
    Clin Pharmacol Ther; 2022 Jul; 112(1):171-180. PubMed ID: 35467014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Familiar outbreak of botulism at Ceará state, Brazil: case report].
    Barboza MM; Santos NF; Sousa OV
    Rev Soc Bras Med Trop; 2011; 44(3):400-2. PubMed ID: 21779684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective survey to evaluate the safety and efficacy of Japanese botulinum antitoxin therapy in Japan.
    Mottate K; Yokote H; Mori S; Horita A; Miyatsu Y; Torii Y; Kozaki S; Iwaki M; Takahashi M; Ginnaga A
    Toxicon; 2016 Feb; 110():12-8. PubMed ID: 26615088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pauci-symptomatic foodborne botulism due to Clostridium botulinum type B with predominant ophthalmologic presentation possibly after consumption of honey.
    Goin P; Hagenkötter B; Gendrin V; Garnier P; Klopfenstein T; Zayet S
    Anaerobe; 2022 Jun; 75():102578. PubMed ID: 35489618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.